September 25, 2022

Gilead can’t escape patent trial over hep c drugs

Pin It

By Scott Graham, From The Recorder It looks as if Gilead Sciences will have to roll the dice on trial next month if it wants to protect the patent rights to its blockbuster hepatitis C treatment. It wouldn’t be the first time. U.S. District Judge Beth Labson Freeman of the Northern District of California on […]